Loading clinical trials...

Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II | Clinical Trials | Clareo Health

COMPLETEDNCT06022380

Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II

The Mucopolysaccharidoses (MPS) are a family of genetic metabolic disorders, caused by specific enzyme deficiencies which result in accumulation of partially degraded glycosaminoglycans (GAGs) within ...

Lead sponsor: Manchester University NHS Foundation Trust•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 1/2

Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)

NCT06181136 · Mucopolysaccharidosis Type IIIA

COMPLETEDPhase 1/2

RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)

NCT04571970 · Mucopolysaccharidosis Type II (MPS II)

COMPLETED

Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III

NCT03161171 · Mucopolysaccharidosis Type I, Mucopolysaccharidosis Type II, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 1, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment46

Start dateSep 2020

Last updatedSep 1, 2023

Condition

Mucopolysaccharidosis Type II

Locations shown

Manchester University NHS Foundation Trust

Manchester, Lancashire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 1, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions